NCT01503437View on ClinicalTrials.gov

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

December 31, 2006

Conditions
Fasting
Interventions
DRUG

Olanzapine OD Tablets 5 mg

Olanzapine OD Tablets 5 mg of Dr. Reddy's Laboratories Limited

Trial Locations (1)

400013

Wellquest Clinical Research, Mumbai

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY